Samsung Biologics fulfills our social roles and responsibilities as a CDMO company in the biologics industry by practicing legal and ethical compliance-oriented management principles and abiding by all applicable laws. To that end, we have a robust Compliance Program, which is the most fundamental aspect of fulfilling our company’s social responsibilities. Through our education and system organization, we ensure compliance becomes the basis of all business activities and decision-making. In addition, our Compliance Program addresses management risks stemming from infringement of intellectual property rights, as well as strengthening our responsibility on the issues of human rights, safety, health, and the environment. We promote compliance with the laws to support our sustainable growth into a world-class company.
Our Compliance Program (CP) is composed of ongoing and integrated systems and activities, aimed at protecting the company and its employees and preventing/minimizing legal risks by requiring its employees to comply with laws and regulations when performing related tasks. of relevant laws and regulations by our employees.
- Compliance Program
- Compliance-driven Organization
- Operation standard
- Corporate Culture
Compliance Program (CP) activities of Samsung Biologics are executed by our management through the following process :
The establishment of CP standard procedures → Execution of education → Inspection and monitoring → Evaluation and reporting.
The Legal & Compliance Management Department establishes and provides CP regulations, detailed guidelines, action standards, and manuals to employees. The department promotes legal compliance by continuous education and monitoring on daily basis. Additionally, it receives inquiries and reports regarding issues and concerns on the compliance of relevant laws and regulations by its employees.
- 01 First stepThe Establishment of CP Standard Procedures
- 02 Second StepExecution of Education
- 03 Third StepInspection and Monitoring
- 04 Fourth StepEvaluation and Reporting
- Key CP Policies
Compliance practice for each category include: protection of confidential information, observance of fair trade, prevention of corruption, maintenance of environmental safety, protection of intellectual property, safeguard of information security, and protection of personal information.
Legal Compliance Management Action Standard
The staff and executives of Samsung Biologics fully recognize the importance of compliance management. Samsung Biologics complies with all applicable laws and internal regulations, accomplishing the objectives including, but not limited to, the following:
1. Healthy Organizational Culture
We will respect the dignity and diversity of individual staff and executives, and comply with the laws related to personnel management.2. Fair Competition
We will respect the free and fair market economic order and comply with the fair trade laws.3. Working together with Subcontractors
We will work with cooperative companies as partners in business and not abuse our bargaining power.4. Anti-Corruption
We will not improperly acquire business opportunities or receive benefits.5. Accounting and Public Announcements
We will accurately record financial information according to internationally recognized accounting standards, and we will sincerely notify the public of required corporate information and important issues.6. Confidential Information and Intellectual Property
We will protect confidential information and intellectual property rights.7. Personal Information
We will protect personal information.8. Safety, Health, and Environment
We will preserve the health and safety of our workers, the public, and the environment.
For questions or comments regarding the legal & compliance management of Samsung Biologics, please send them to the address below:AddressLegal & Compliance Team, Compliance Manager, Samsung Biologics, 300, Songdo bio-daero, Yeonsu-gu, Incheon 21987, Republic of Korea
Samsung Biologics operates the ISO37001 ABMS (Anti-Bribery Management System) in order to promote transparency, comply with laws and regulations, practice social responsibility and build trust with stakeholders.
ISO37001 is the international standard for anti-bribery management systems. The standard sets out requirements for measures to monitor and prevent bribery across the organization and its business activities.
We have obtained ISO37001 certification from the British Standards Institution (BSI) to substantiate the efficacy of our ABMS.
Our ABMS prevents bribery by monitoring company activities and implementing additional preventative measures for activities identified to have risks.
For the effective operation of our ABMS, we provide training for employees, conduct bribery risk assessments, set measurable goals, perform internal audits and express our commitment to preventing bribery.
As a leading global CDMO company, our business principles are to comply with laws and ethical standards, maintain a clean organizational culture and fulfil our duty as global corporate citizens.
To act in accordance with these principles and promote Compliance, we declare the following as our Anti-Bribery Policy.
- ❶ The Company shall implement, operate and continually improve the Anti-Bribery Management System.
- ❷ The Company shall operate a whistleblowing channel through which concerns of bribery may be raised in good faith and ensure that no harm be done to the whistleblower as a consequence of their actions.
- ❸ Employees shall comply with Company policies and anti-bribery laws applicable for conducting Company business.
- ❹ Employees shall neither conduct nor participate in any acts of bribery.
Samsung Biologics President & CEO